Controlled Diets for Dietary Biomarker Identification in Healthy Adults

(P1-SDBDC Trial)

SA
ML
Overseen ByMarian L. Neuhouser
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to discover better ways to measure dietary intake by identifying dietary biomarkers, indicators found in blood or urine that reveal what someone has been eating. Participants will follow controlled diets featuring either beef and pinto beans or eggs and black beans. Different groups will consume these foods in varied orders to help identify these biomarkers. The trial suits healthy adults with stable weight, no major food allergies or gastrointestinal issues, and a willingness to visit the study center multiple times. As an unphased trial, it offers participants the chance to contribute to groundbreaking research in nutrition science.

Will I have to stop taking my current medications?

The trial requires that participants stop taking certain medications, including diuretics, steroids, opiates, and some psychiatric and anti-lipid medications. Study staff will review your medications to determine eligibility, so you may need to stop taking some of your current medications.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Research has shown that controlled feeding studies, such as those involving beef and pinto beans or eggs and black beans, are generally safe for healthy adults. These studies analyze blood and urine samples to understand how the body processes different foods. Participants typically follow these specific diets without major issues.

Previous research indicates that similar controlled diet studies have been well-tolerated. Participants consume set amounts of food under close supervision, reducing risks. Foods like beef, beans, and eggs are common in many diets and do not cause significant side effects when eaten in normal amounts.

Although specific data on negative effects from these studies is lacking, the study's focus on understanding dietary effects rather than testing a new drug suggests safety. The use of common foods and established methods supports the belief that these diets are safe.12345

Why are researchers excited about this trial?

Researchers are excited about this trial because it explores how different controlled diets can help identify dietary biomarkers in healthy adults. Unlike traditional studies that might focus on single nutrients or foods, this trial examines combinations like beef with pinto beans and eggs with black beans. By assessing these varied diets, researchers hope to uncover specific biomarkers that could lead to more personalized nutrition recommendations. This could revolutionize how we understand the impact of diet on health, potentially leading to more tailored dietary guidelines for individuals.

What evidence suggests that this trial's dietary interventions could be effective for identifying dietary biomarkers?

This trial will study controlled diets to identify dietary biomarkers in healthy adults. Participants will be assigned to different treatment arms.

In some arms, participants will consume diets involving beef and pinto beans. Research has shown that pinto beans can improve gut health by supporting beneficial bacteria and boosting the immune system. Additionally, when beef and pinto beans are consumed together, researchers can identify specific markers in the body that accurately reflect dietary intake.

In other arms, participants will consume diets involving eggs and black beans. Studies indicate that eggs provide important nutrients without requiring the replacement of other foods in the diet. Black beans are linked to health benefits such as reducing inflammation and supporting heart health. These foods are being studied to help identify markers that enhance the reporting and evaluation of diets.12367

Who Is on the Research Team?

ML

Marian L. Neuhouser

Principal Investigator

Fred Hutchinson Cancer Center

JW

Johanna W. Lampe, PhD, RD

Principal Investigator

Fred Hutchinson Cancer Center

Are You a Good Fit for This Trial?

Healthy adults over 18, with a BMI of 18.5-39.9 kg/m2, who can visit the Fred Hutch campus 16 times for the study are eligible. Exclusions include those with certain gastrointestinal disorders, recent surgery or cancer treatment, substance use that they're unwilling to stop during the study, and various other health conditions and medication uses.

Exclusion Criteria

I have a history of serious gut disorders like Crohn's or celiac disease.
Pregnant or lactating
Use of illicit drugs and not willing to abstain during feeding periods
See 16 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Controlled Feeding Period

Participants undergo a 2-day run-in of controlled feeding followed by a 7-day feeding period for each of the three feeding periods.

9 days per feeding period
3 visits (in-person) per feeding period

Washout

A 7-day washout period between each feeding period to reset dietary intake.

7 days

Follow-up

Participants are monitored for safety and effectiveness after the feeding trials, with specimen collection for study outcomes and future studies.

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Controlled feeding study of beef and/or pinto beans
  • Controlled feeding study of eggs and/or black beans
Trial Overview The trial is testing how well blood and urine biomarkers can measure diet by having participants eat controlled diets including beef/pinto beans or eggs/black beans. Researchers will analyze these biological samples to identify reliable dietary intake indicators.
How Is the Trial Designed?
6Treatment groups
Experimental Treatment
Group I: 6) Black bean then egg then half black bean and half eggExperimental Treatment1 Intervention
Group II: 5) Half egg and half black bean, then black bean then eggExperimental Treatment1 Intervention
Group III: 4) Egg then half Egg and half black bean then black beanExperimental Treatment1 Intervention
Group IV: 3) Pinto Bean then Beef then half pinto bean and half beefExperimental Treatment1 Intervention
Group V: 2) Half pinto bean and half beef then pinto bean then beefExperimental Treatment1 Intervention
Group VI: 1) Beef then half beef and half pinto bean then pinto beanExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Marian Neuhouser

Lead Sponsor

Trials
2
Recruited
60+

United States Department of Agriculture - National Institute of Food and Agriculture (USDA-NIFA)

Collaborator

Trials
2
Recruited
60+

University of Nebraska

Collaborator

Trials
563
Recruited
1,147,000+

University of Washington

Collaborator

Trials
1,858
Recruited
2,023,000+

Duke University

Collaborator

Trials
2,495
Recruited
5,912,000+

Published Research Related to This Trial

This literature review identified promising dietary biomarkers that can accurately reflect the intake of various food groups in the Western diet, which is crucial for epidemiological studies on health and disease.
While many biomarker candidates show moderate to strong correlations with food intake, further research is needed to fully validate their effectiveness, particularly regarding their dose response and reproducibility over time.
Dietary biomarkers-an update on their validity and applicability in epidemiological studies.Landberg, R., Karra, P., Hoobler, R., et al.[2023]
In a controlled feeding study with 153 postmenopausal women, serum biomarkers for vitamins and carotenoids were found to effectively reflect dietary intake, showing strong correlations with nutrient consumption.
The study suggests that these serum biomarkers can serve as reliable indicators of nutrient intake, similar to established urinary recovery biomarkers for energy and protein, although further research is needed to assess fatty acid intake measures.
Dietary biomarker evaluation in a controlled feeding study in women from the Women's Health Initiative cohort.Lampe, JW., Huang, Y., Neuhouser, ML., et al.[2023]
In a randomized crossover trial involving 64 men, a legume-enriched, low-glycemic index diet significantly improved inflammation markers (C-reactive protein and soluble tumor necrosis factor receptors) compared to a high-glycemic American diet.
Both diets led to changes in fasting glucose levels, but only the legume diet showed a favorable trend in reducing inflammation, suggesting that dietary modifications can positively impact insulin resistance and inflammation biomarkers.
Consumption of a legume-enriched, low-glycemic index diet is associated with biomarkers of insulin resistance and inflammation among men at risk for colorectal cancer.Hartman, TJ., Albert, PS., Zhang, Z., et al.[2023]

Citations

Controlled Diets for Dietary Biomarker Identification in Healthy ...Trial Overview The trial is testing how well blood and urine biomarkers can measure diet by having participants eat controlled diets including beef/pinto beans ...
The Dietary Biomarkers Development ConsortiumEach trial will involve 3 7-d DR feeding periods and 2 PK evaluations and will pair an animal- and plant-based protein food (beef and pinto ...
The Dietary Biomarkers Development Consortium: An ...Each trial will involve 3 7-d DR feeding periods and 2 PK evaluations and will pair an animal- and plant-based protein food (beef and pinto beans; eggs and ...
a 14-d controlled feeding study of weighed food intake - PMCThe aim of this study was to evaluate associations between metabolites and weighed food and beverage intake in a controlled feeding study of habitual diet.
Pinto beans modulate the gut microbiome, augment MHC II ...This study evaluated the effects of pinto beans (PB) supplementation on cecal bacteria, short-chain fatty acids (SCFAs), distal ileal antigen ...
NCT05616585 | Dietary Biomarkers Intervention CoreThe purpose of this controlled feeding trial is to establish an Intervention Core, equipped to perform tightly controlled pharmacokinetic (PK) and dose- ...
Seattle Dietary Biomarker Development CenterThe Seattle Dietary Biomarker Development Center will use two phases of controlled feeding studies for metabolomics discovery of MyPlate foods, food groups and ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security